Likelihood of recurrence increases when post-surgical radiation therapy (RT) is delayed in patients with endometrial carcinoma, according to results of a retrospective study by researchers at Henry Ford Health System, Detroit, MI. The findings were presented at the 54th annual meeting of the American Society for Radiation Oncology (ASTRO) in Boston in October.
FDA grants 510(k) clearance to chemiluminescence-based immunoassay
Published: January 10th 2025 | Updated: January 10th 2025The automated chemiluminescence-based immunoassay has received clearance for free testosterone, providing enhanced diagnostic options to a multitude of conditions.
Read More